DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksSchließen
Referenz
Li G, Cook DJ, Levine MA. , et al; PROTECT Investigators for the Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.
Australian and New Zealand Intensive Care Society Clinical Trials Group. Competing risk analysis for evaluation of dalteparin versus unfractionated heparin for venous thromboembolism in medical-surgical critically ill patients.
Medicine (Baltimore) 2015;
94 (36) e1479
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.